ITL Group

ITL Group (a G&H company) is the award-winning medical device design, development and manufacturing partner of life-saving medical technology, diagnostic devices and analytical instruments.

Established in 1977, ITL Group, based in Kent, have worked on more than 500 projects at various stages of their product development life-cycle.

With clients ranging from one-man start-ups to world-leading organisations, ITL have the capability to take your project from conceptualisation all the way through to full scale manufacture and aftersales support as part of our complete product development service.

Our facilities in the UK, USA and China enable us to offer our clients world-wide support and access to global supply chains and markets.

At ITL we approach things a little differently than the average contract design and manufacturing partner, and believe in working with, and not simply for, our clients.

ITL Group is audited and accredited to ISO 9001, ISO 13485 and FDA CFR 21 part 820.

ITL are proud to maintain a highly controlled Quality Management System to assist you in the design, development and manufacture of medical products for worldwide markets

BSI Assurance Mark ISO 9001 & ISO 13485

“We chose to collaborate with ITL on this project because of their considerable experience with in vitro diagnostic (IVD) and microfluidic development. Working in partnership with their engineers has been an absolute pleasure; their systematic and disciplined approach has been invaluable to us throughout this journey.” Mika Laitinen, Chief Executive Officer at Magnasense Technologies Oy

The latest from ITL

News
ITL increases critical instrument production during COVID-19 pandemic

As a global design and manufacturing partner of life-saving medical devices and diagnostic instruments, ITL Group (a G&H company) is an essential link in the healthcare supply chain. ITL is currently manufacturing and delivering instrumentation designed to improve respiratory function and oxygen uptake as part of a ventilator system for patients in critical care including those due to COVID-19, as well as hygiene monitoring devices and rapid diagnostic testing platforms.

Read more >

Resource
COVID-19 & MedTech: How to effectively manage supply chain disruption

It’s impossible to anticipate the arrival of global crises such as COVID-19, but the resulting impact on supply chains is putting added pressure on manufacturers worldwide – but what action can you take to build a more resilient supply chain in a time of crisis?

Read more >

Case Study
Magnasense

From lab based analysis to mobile and disposable ‘point of care testing’ (POCT)

View this case study >